Literature DB >> 20580749

Inhibitory control and response latency differences between C57BL/6J and DBA/2J mice in a Go/No-Go and 5-choice serial reaction time task and strain-specific responsivity to amphetamine.

Maarten Loos1, Jorn Staal, Anton N M Schoffelmeer, August B Smit, Sabine Spijker, Tommy Pattij.   

Abstract

Among the best-replicated and most heritable endophenotypes of attention-deficit/hyperactivity disorder (ADHD) are deficits in attention, inhibitory response control and larger intra-individual variability in response latencies. Here, we explored the presence of these heritable ADHD endophenotypes in two commonly used inbred mouse strains, C57BL/6J and DBA/2J, and investigated whether treatment with the stimulant amphetamine affected these phenotypes. Both in an operant Go/No-Go task and 5-choice serial reaction time (5-CSRT) task, DBA/2J mice showed reduced inhibitory response control compared with C57BL/6J mice. Mean correct response latencies of DBA/2J mice were slower in both tasks. Analysis of the distribution of correct response latencies suggested similar processing speed, but DBA/2J mice displayed larger intra-individual variability. Amphetamine did not affect inhibition in the Go/No-Go task but increased omission errors. In contrast, in the 5-CSRT task, amphetamine did not affect omission errors but impaired inhibitory response control, specifically in C57BL/6J mice. The dopamine uptake inhibitor, GBR 12909, mimicked this effect and decreased accurate choice, specifically in C57BL/6J mice, indicating that dopamine modulates inhibitory response control and attention in the murine 5-CSRT task. Amphetamine did not affect response distributions in either task. Furthermore, we extended previous reports on differences in the brain dopamine system of DBA/2J and C57BL/6J mice, by showing differential gene expression levels of three dopamine receptors (Drd1, Drd4 and Drd5) in the mPFC. In conclusion, genetic differences between DBA/2J and C57BL/6J mice translate into multiple ADHD-related phenotypes, indicating that these strains are valuable resources to understand genetic mechanisms underlying ADHD-relevant phenotypes. Copyright (c) 2010 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20580749     DOI: 10.1016/j.bbr.2010.05.027

Source DB:  PubMed          Journal:  Behav Brain Res        ISSN: 0166-4328            Impact factor:   3.332


  45 in total

1.  A single administration of methamphetamine to mice early in the light period decreases running wheel activity observed during the dark period.

Authors:  Nobue Kitanaka; Junichi Kitanaka; F Scott Hall; George R Uhl; Kaname Watabe; Hitoshi Kubo; Hitoshi Takahashi; Tomohiro Tatsuta; Yoshio Morita; Motohiko Takemura
Journal:  Brain Res       Date:  2011-10-26       Impact factor: 3.252

2.  Behavioral inhibition in mice bred for high vs. low levels of methamphetamine consumption or sensitization.

Authors:  Travis M Moschak; Katherine A Stang; Tamara J Phillips; Suzanne H Mitchell
Journal:  Psychopharmacology (Berl)       Date:  2012-02-04       Impact factor: 4.530

3.  Serotonin (5-hydroxytryptamine) 5-HT(2A) receptor: association with inherent and cocaine-evoked behavioral disinhibition in rats.

Authors:  Noelle C Anastasio; Erin C Stoffel; Robert G Fox; Marcy J Bubar; Kenner C Rice; Frederick G Moeller; Kathryn A Cunningham
Journal:  Behav Pharmacol       Date:  2011-06       Impact factor: 2.293

4.  Effects of amphetamine, morphine, and CP 55, 940 on Go/No-Go task performance in rhesus monkeys.

Authors:  Wouter Koek; Lisa R Gerak; Charles P France
Journal:  Behav Pharmacol       Date:  2015-08       Impact factor: 2.293

5.  The effects of reduced dopamine transporter function and chronic lithium on motivation, probabilistic learning, and neurochemistry in mice: Modeling bipolar mania.

Authors:  Morgane Milienne-Petiot; James P Kesby; Mary Graves; Jordy van Enkhuizen; Svetlana Semenova; Arpi Minassian; Athina Markou; Mark A Geyer; Jared W Young
Journal:  Neuropharmacology       Date:  2016-10-11       Impact factor: 5.250

6.  Chronic valproate attenuates some, but not all, facets of mania-like behaviour in mice.

Authors:  Jordy van Enkhuizen; Mark A Geyer; Klaas Kooistra; Jared W Young
Journal:  Int J Neuropsychopharmacol       Date:  2012-11-20       Impact factor: 5.176

Review 7.  Comprehensive neurocognitive endophenotyping strategies for mouse models of genetic disorders.

Authors:  Michael R Hunsaker
Journal:  Prog Neurobiol       Date:  2012-01-13       Impact factor: 11.685

8.  DCC Receptors Drive Prefrontal Cortex Maturation by Determining Dopamine Axon Targeting in Adolescence.

Authors:  Lauren M Reynolds; Matthew Pokinko; Angélica Torres-Berrío; Santiago Cuesta; Laura C Lambert; Esther Del Cid Pellitero; Michael Wodzinski; Colleen Manitt; Paul Krimpenfort; Bryan Kolb; Cecilia Flores
Journal:  Biol Psychiatry       Date:  2017-06-16       Impact factor: 13.382

9.  Responding for conditioned reinforcement in C57BL/6 and CD-1 mice, and Sprague-Dawley rats: Effects of methylphenidate and amphetamine.

Authors:  J D Caleb Browne; Ashlie D Soko; Paul J Fletcher
Journal:  Psychopharmacology (Berl)       Date:  2014-05-08       Impact factor: 4.530

Review 10.  Consideration of species differences in developing novel molecules as cognition enhancers.

Authors:  Jared W Young; J David Jentsch; Timothy J Bussey; Tanya L Wallace; Daniel M Hutcheson
Journal:  Neurosci Biobehav Rev       Date:  2012-10-12       Impact factor: 8.989

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.